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OBJECTIVE — To determine whether an electronic order template for basal-bolus insulin
ordering improves mean blood glucose in hospitalized general medical patients with hypergly-
cemia and type 2 diabetes.
RESEARCH DESIGN AND METHODS — We randomly assigned internal medicine
resident teams on acute general medical ﬂoors to the use of an electronic insulin order template
orusualinsulinordering.Wemeasureddiabetescareparametersfor1monthonallpatientswith
type 2 diabetes and blood glucose 60 mg/dl or 180 mg/dl treated by these physicians.
RESULTS — Intervention group patients (n  65) had mean glucose of 195  66 mg/dl.
Control group patients (n  63) had mean glucose of 224  57 mg/dl (P  0.004). In the
intervention group, there was no increase in hypoglycemia.
CONCLUSIONS — Access to a computer insulin order template was associated with im-
proved mean glucose levels without increasing hypoglycemia in patients with type 2 diabetes.
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P
hysiological, basal-bolus insulin
prescribing is safe, effective (1), and
the standard of care in hospitalized
patients with type 2 diabetes and hyper-
glycemia (2). Yet only about half of such
patientsareprescribedbasalinsulininthe
hospital (3). Order templates to support
basal-bolus insulin prescribing (usually
as part of a comprehensive inpatient dia-
betes quality improvement program)
havebeeneffectiveinimprovingglycemia
in observational trials (4–8). Random-
ized trials have shown more modest ef-
fects (9,10). Knowledge of appropriate
insulin ordering is a barrier to ordering
basal-bolus insulin among inpatient
providers (11–13).
We tested the hypothesis that giving
internal medicine residents access to an
electronic insulin order template would
be more effective than usual insulin or-
dering in lowering mean blood glucose in
medical inpatients with type 2 diabetes.
RESEARCH DESIGN AND
METHODS— We piloted a simple
electronic insulin order template based
on previously studied protocols (1,4,14)
and internal review by diabetologists and
pharmacistsatatertiarycaremedicalcen-
terwithaproprietarycomputerizedorder
entry system. The template presents se-
quentialscreenslinkingtoaweight-based
insulin dose calculator and facilitating
prescriptionofatotaldailydoseofinsulin
of 0.5 units/kg, half in basal glargine and
halfinprandialaspart,withsupplemental
aspart (supplementary Appendix 1, avail-
able at http://care.diabetesjournals.org/cgi/
content/full/dc10-0964/DC1).
Using a computerized coin toss, we
randomly assigned seven teams of provid-
ers (42 internal medicine residents) work-
ing in general medical acute care units to
have the option to use the order template
(intervention group) or to use usual insulin
ordering (control group). All residents re-
ceived a 30-min educational session and a
two-page pamphlet on how to prescribe
and titrate basal-bolus insulin (supplemen-
tary Appendix 1).
We identiﬁed all patients prescribed
insulin by these providers during the
study period (30 April 2009 to 27 May
2009). We excluded patients with type 1
diabetes(n11)andtype2diabeteswith
blood glucose between 60 and 180 mg/dl
because the order set was designed to ap-
plytohyperglycemiainpatientswithtype
2 diabetes without other risks for hypo-
glycemia(i.e.,liverorrenalfailure).Diag-
nosis of type 2 diabetes was conﬁrmed by
chart review. We determined age, sex,
race,lengthofstay,andprimarydiagnosis
of the patients from the medical record.
Glycemic parameters were calculated
from point-of-care glucose values, using
mean glucose as the main outcome for its
easy interpretability and similarity to
other metrics (15). Secondary outcomes
included the rate of prolonged hypergly-
cemia (three consecutive glucose values
240 mg/dl); hospital-stay rate of hypo-
glycemia(anyglucosevalue60mg/dlor
40mg/dl);therateofuseofslidingscale
insulin alone (having sliding scale insulin
orderswithoutanyotherinsulinordersat
any point during admission); rate of ini-
tial prescription of basal insulin (any or-
derforlong-actinginsulinwithin1dayof
hospital admission); and basal insulin at
any time (any order for long-acting insu-
lin at any time during the hospital stay).
The study had 80% power to detect a
difference in mean glucose of 30 mg/dl
between groups, assuming SD of 60 mg/
dl.WeperformedStudentttestsandWil-
coxon rank sum tests to determine
differences between means and medians
of continuous and non-normally distrib-
utedvariablesandperformed
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repeatedmeanglucoseestimatesaccount-
ing for repeated (glucose) and correlated
(provider) measures and adjusting for
baseline glucose (supplementary Appen-
dix 2). All analyses were performed with
SAS version 9.1. The protocol was ap-
proved by the Partners Healthcare Insti-
tutional Review Board.
RESULTS— During the 4-week study
period, 144 insulin-treated patients with
type2diabeteswereadmittedtotheseven
study teams. Mean glucose was 186  56
mg/dl in intervention patients and 206 
61 mg/dl in control patients (P  0.004).
Excluding 16 patients whose point-of-
care glucose values were between 60 and
180 mg/dl left a study sample size of 128;
127 had at least one value 180 mg/dl
and 1 had a glucose value 60 mg/dl.
Sixty-three patients were treated by pro-
viders with access to the order template
(interventiongroup),and65weretreated
by providers who received the pamphlet
and brief teaching session alone (control
group). There were no signiﬁcant differ-
ences between groups in patient age, sex,
race, length of stay, or primary diagnosis.
Mean glucose was signiﬁcantly better in
the intervention group (194  66 mg/dl
vs.22457mg/dl,P0.004)(Table1).
The rates of basal insulin orders, any hy-
poglycemia,andseverehypoglycemiadid
not differ between groups.
CONCLUSIONS — In this random-
ized trial of a computer order template to
support basal-bolus insulin prescribing
for general acute medical inpatients with
type 2 diabetes, we found an improved
mean glucose level in patients of provid-
ers given access to the order template.
Mean glucose levels in both groups
were higher than the goal for inpatient
glucose levels in noncritically ill patients
(2), and mean basal insulin doses were
low, consistent with persistent inade-
quate treatment. The rate of basal insulin
ordered at admission was low and in-
creased equivalently in both groups to a
rate over 60%; this compares favorably to
a rate of 43% in a national sample of in-
sulin-treatedinpatientswithtype2diabe-
tes (3). The rate of sliding scale insulin
alone (35%) was equivalent to that of a
comparable national sample (35%) (3).
Given the efﬁcacy of basal-bolus treat-
ment, it seems even a low rate of appro-
priate insulin ordering may be associated
with modest improvement in mean glu-
coselevels.Useoftheordertemplatemay
have been limited by its optional use and
the minimal support for the order set, in
contrast to similar programs at other cen-
ters (9,10).
In conclusion, access to an electronic
basal-bolusinsulinordertemplatewasas-
sociated with a signiﬁcant improvement
in glycemic control among patients with
type 2 diabetes without increasing the
rateofhypoglycemiabutdidnotsubstan-
tially change insulin ordering behavior. A
“smarter” template with alerts based on
glucose levels and nutritional status and
forced rather than optional use, coupled
with more intensive implementation sup-
port, might further improve the care of
hospitalizedpatientswithtype2diabetes.
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